Literature DB >> 5335054

Homograft reaction in amyloidotic mice.

P Ranlov, E Jensen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5335054     DOI: 10.1111/apm.1966.67.2.161

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand        ISSN: 0365-5555


× No keyword cloud information.
  8 in total

1.  Lymphocyte transformation in patients with amyloidosis.

Authors:  T Lehner; J S Cameron; R G Ward
Journal:  Clin Exp Immunol       Date:  1970-03       Impact factor: 4.330

2.  Amyloidosis in neonatally thymectomized and anti-lymphocyte serum treated mice.

Authors:  E Clerici; P Mocarelli; E Smeraldi; M L Villa
Journal:  Clin Exp Immunol       Date:  1969-07       Impact factor: 4.330

3.  Quantitative studies on the T cell populations in spleens from amyloidotic and non-amyloidotic mice.

Authors:  F Hardt; M H Claësson
Journal:  Immunology       Date:  1972-04       Impact factor: 7.397

4.  Cellular immunity in casein-induced amyloidosis.

Authors:  E S Cathcart; M Mullarkey; A S Cohen
Journal:  Immunology       Date:  1971-06       Impact factor: 7.397

5.  Casein-induced experimental amyloidosis. III. Response to mitogens, allogeneic cells, and graft-versus-host reactions in the murine model.

Authors:  M A Scheinberg; E S Cathcart
Journal:  Immunology       Date:  1974-11       Impact factor: 7.397

6.  Transfer amyloidosis. I. Studies on the transfer of various lymphoid cells from amyloidotic mice to syngeneic nonamyloidotic recipients. II. Induction of amyloidosis in mice with spleen, thymus and lymph node tissue from casein-sensitized syngeneic donors.

Authors:  F Hardt
Journal:  Am J Pathol       Date:  1971-11       Impact factor: 4.307

7.  Cell-mediated immunity in amyloidosis secondary to lepromatous leprosy.

Authors:  E M Anders; K P McAdam; R F Anders
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

8.  Mutually exclusive occurrence of amyloidosis and thymic leukaemia in casein treated AKR mice.

Authors:  P Ebbesen
Journal:  Br J Cancer       Date:  1974-01       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.